Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Biotechnology
  Year: 2010 | Volume: 9 | Issue: 2 | Page No.: 157-163
DOI: 10.3923/biotech.2010.157.163
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
An in Silico Development of Selective Inhibitor for Histamine Receptors
Fakher Rahim

Abstract:
This study aimed to design a reliable homology model of human histamine H1 and H4 receptors (hH1R, hH4R), that would guide future biochemical and genetic efforts in its evaluation as a potential therapeutic target. Furthermore, these accurate models could aid in the structure-based inhibitor design for antagonists against the histamine H1 and H4 receptors. The homologous protein sequences of histamine receptors were retrieved from the NCBI REFSEQ which by using the sequence alignment program ClustalW alignment of the human histamine receptors sequence with Bovine Rhodopsin was conducted to locate the homology aligned regions. The present study found that Asp107 and Asn198 are in favorable positions for anchoring histamine. Identification of novel interaction sites for antagonist binding mutational data suggest a crucial role for Asp107, Trp158, Phe 432 and Phe 435 in antagonist binding. This study identified several novel amino acids at the binding site. Binding mode analysis of known H1 antagonists four known H1 antagonists (mepyramine, acrivastine, desloratadine, loratadine) were docked successfully to the binding site of the hH1R model by FlexiDock. The ligand used for optimizing the receptor model, the pharmacophore constraints and the different scoring functions applied in high throughput docking had all significant effect on the results. This research identified 16 compounds with 7 significant H4 activities representing an overall hit rate of 5.2%. To the best of our knowledge, this is one of the largest structure-based virtual screenings, where the virtual hits were confirmed by an in vitro assay. Moreover, this is the first structure-based drug design study reported on the hH4R. After the virtual screening, we identified several novel ligands with significant H4 affinity. These scaffolds can serve as starting points in the development of potent and selective H4 ligands in future.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Parallel Particle Swarm Optimization for Global Multiple Sequence Alignment
  •    Isolation, Characterization and Pharmacological Evaluation of 8-chloro-3 (1-methyl-piperidene-4-yl) 5H-benzo [5, 6] Cyclohepta [1, 2b] Pyridene-11(6H)-one from Loratadine
  •    In silico Comparison of Simple Sequence Repeats in High Nucleotides-Rich Genomes of Microorganism
How to cite this article:

Fakher Rahim , 2010. An in Silico Development of Selective Inhibitor for Histamine Receptors. Biotechnology, 9: 157-163.

DOI: 10.3923/biotech.2010.157.163

URL: https://scialert.net/abstract/?doi=biotech.2010.157.163

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

       

       

Curve Bottom